Asia · Regional markets · Pulse (Maeil Business)

SK Bioscience Q3 revenue rises 21%, operating loss narrows

Published by Pulse (Maeil Business) · South Korea 14 h ago

SK Bioscience reported a 21 percent increase in third-quarter revenue Thursday, driven by growth at its German contract manufacturing subsidiary and stronger vaccine sales, while…

Read the full article on Pulse (Maeil Business) Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (pulse.mk.co.kr)

Also worth reading

Mint

SK Bioscience Q3 revenue rises 21%, operating loss narrows

Share

Also worth reading

Quick Mart IPO Draws Strong Demand as Kenyan Listings Pick Up

AI trade rout: Are global financial markets showing signs of a bigger crisis?

Samvat 2082: Commodities witness sharp volatility as crude surges

US hiring blows past forecasts as unemployment falls to 4.1%

Bitcoin selloff eases as investors explore cautious recovery

Israel’s Iran war leaves Netanyahu estranged from Washington